Lorvotuzumab Biosimilar (NCAM1 / CD56 Reference Antibody)
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab) ) is a humanized monoclonal antibody that binds CD56 (NCAM1) . Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine.
Product Specifications
Target
Lorvotuzumab Biosimilar (Anti-NCAM1 / CD56 Reference Antibody)
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP64565_P050 100 µL
ELOVL6 antibody - C-terminal region (ARP64565_P050)
Sign In for Pricing
View Details 
PC100577-01 100 mg
(R) -2-Amino-2- (3-fluorophenyl) ethan-1-ol hydrochloride
Sign In for Pricing
View Details PC100577-02 250 mg
(R) -2-Amino-2- (3-fluorophenyl) ethan-1-ol hydrochloride
Sign In for Pricing
View Details PC100577-03 1 g
(R) -2-Amino-2- (3-fluorophenyl) ethan-1-ol hydrochloride
Sign In for Pricing
View Details PC100577-04 5 g
(R) -2-Amino-2- (3-fluorophenyl) ethan-1-ol hydrochloride
Sign In for Pricing
View Details 